Dermacell AWM Product Specifications
Dermacell AWM®
Human Acellular Dermal Matrix (hADM)
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
- Biohospitable: All cells and ≥ 97% donor DNA removed to potentially minimize any adverse patient response.1
- Intact Acellular Framework: Retains native growth factors, collagen and elastin.2
- Room Temperature Storage: Ready to use out of the package (15°C- 30°C).
- Strength: Pull-out strength and load to failure are comparable to native dermis.3,4
- Sterile: Sterilized to a Sterility Assurance Level (SAL) of 10-6, medical device grade sterility.5
- Structural Support: Facilitates use with sutures, staples.
- Proven: Conducted the largest randomized controlled trial (RCT) to date using hADM in chronic wounds.6
Clinical Application
- Chronic wounds such as diabetic foot ulcers (DFUs), venous stasis ulcers (VSUs), arterial ulcers and pressure ulcers, as well as dehisced surgical wounds and traumatic burns
- Dermacell AWM can be used over exposed tendon, bone, joint capsule, and muscle
| Order Code | Description | Sizing |
|---|---|---|
| DCELL100 | Unmeshed | 2 x 2 cm (0.2 - 1 mm thickness) |
| DCELL101 | Unmeshed | 4 x 4 cm (0.2 - 1 mm thickness) |
| DCELL102 | Unmeshed | 5 x 7 cm (0.2 - 1 mm thickness) |
| DCELL103 | Unmeshed | 6 x 7 cm (0.2 - 1 mm thickness) |
| DCELL104 | Unmeshed | 4 x 8 cm (0.2 - 1 mm thickness) |
| DCELL110 | Meshed | 2 x 2 cm (0.2 - 1 mm thickness) |
| DCELL111 | Meshed | 3 x 3 cm (0.2 - 1 mm thickness) |
| DCELL112 | Meshed | 4 x 4 cm (0.2 - 1 mm thickness) |
| DCELL152 | Meshed | 5 x 7 cm (0.2 - 1 mm thickness) |
| DCELL153 | Meshed | 6 x 7 cm (0.2 - 1 mm thickness) |
| DCELL154 | Meshed | 4 x 8 cm (0.2 - 1 mm thickness) |
| DCELL155 | Meshed | 5 x 9 cm (0.2 - 1 mm thickness) |
| DCELL156 | Meshed | 4 x 10 cm (0.2 - 1 mm thickness) |
| DCELL157 | Meshed | 6 x 10 cm (0.2 - 1 mm thickness) |
| DCELL158 | Meshed | 8 x 10 cm (0.2 - 1 mm thickness) |
| DCELL159 | Meshed | 8 x 12 cm (0.2 - 1 mm thickness) |
References
- LifeNet Health 10-006, Process PQ, Devitalization of Dermal Allografts.
- LifeNet Health, TR 0292, LifeNet Health’s Decellularized Dermis, DermACELL, Comparison to the USP Monograph, Scaffold Human Dermis.
- LifeNet Health TR-0119, Assessment of the Impact of Glycerol Treatment and Gamma Irradiation on the Uniaxial Tensile Strength of Acellular Dermis.
- LifeNet HealthTR-0148, A Preliminary Evaluation of the Suture Retention Strength of Acellular Dermis.
- LifeNet Health 10-008, Process, PQ, Method 2B Terminal Sterilization Validation for the Devitalized Dermis Allografts Family.
- Cazzell, S., Vayser, D., Pham H., et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair and Regeneration. 2017.